KDM1A and hepatocellular carcinoma: Although the above studies suggested that LSD1 inhibitors exhibited potential for HCC treatment or enhanced sensitivity of small molecular multikinase inhibitors against unresectable HCC, their low efficiency hindered their further use for treating HCC.